Clinical trial

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery…

NCT00235144 · Cordis US Corp., Industry · Completed

Key facts

NCT number NCT00235144
Title The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
Official title E-Sirius Study: a European, Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions
Acronym E-SIRIUS
Lead sponsor Cordis US Corp., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions sirolimus-coated Bx Velocity stent, uncoated Bx Velocity stent
Enrollment 353
Start date Mar 1, 2001
Primary completion Oct 1, 2002
Completion Sep 1, 2008
First posted Oct 10, 2005
Last update posted May 11, 2009
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies